November 13, 2024 09:15 AM EST
Deals
Manufacturing

Ot­su­ka and ICU Med­ical forge IV man­u­fac­tur­ing net­work to sup­ply the US

Anna Brown

News Reporter

Ot­su­ka Phar­ma­ceu­ti­cal Fac­to­ry is pay­ing $200 mil­lion to the med­ical equip­ment com­pa­ny ICU Med­ical for an al­liance to sup­ply IV prod­ucts to the US. …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

FDA ap­proves Hu­ma­cyte’s lab-grown blood ves­sels in mile­stone for re­gen­er­a­tive med­i­cine

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

Ac­cel­er­at­ed ap­proval brings Pfiz­er's BRAF in­hibitor to first-line pa­tients

Sofinno­va out­lines $550M fund af­ter IPOs and M&A deals

A service from the Financial Times